Global Targeted Drugs for Allergic Diseases Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Anaphylaxis is an inappropriate reaction of the immune system to normal harmless substances. It generally has a rapid onset, strong reaction, and rapid subsidence. It has obvious genetic tendencies and individual differences. Currently, the prevalence of allergic diseases is increasing rapidly worldwide, affecting approximately 25% of the global population. Abnormalities in type 2 immune pathways are important factors in inducing allergic diseases. Type 2 immune pathway refers to an inflammatory pathway in which Th2 cells (T helper 2) play a key role, and various cytokines such as IL-4, IL-5, IL-13, and TSLP are involved. Depending on where the inflammatory reaction occurs, abnormal type 2 immune pathways can induce different allergic diseases, such as skin (atopic dermatitis, chronic spontaneous urticaria, etc.), respiratory tract (chronic sinusitis, asthma, chronic obstruction, etc.) lung disease, etc.), digestive tract (eosinophilic esophagitis), cardiovascular (eosinophilic granulomatous vasculitis), etc. Biological targeted drugs mainly reduce the inflammatory response and activity of immune cells by binding to targets such as specific regulatory factors in the type 2 immune pathway; Small molecule targeted drugs include JAK inhibitors and TYK2 inhibitors, which exert immunomodulatory effects by blocking the JAK/STAT pathway. Compared with traditional anti-allergic drugs, targeted drugs have better efficacy in severe or drug-resistant patients, and the drugs themselves are safer, and have gradually become the mainstream trend in the development of anti-allergic drugs.
The global Targeted Drugs for Allergic Diseases market size is projected to grow from US$ 36340 million in 2024 to US$ 91900 million in 2030; it is expected to grow at a CAGR of 16.7% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Targeted Drugs for Allergic Diseases Industry Forecast” looks at past sales and reviews total world Targeted Drugs for Allergic Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for Allergic Diseases sales for 2023 through 2029. With Targeted Drugs for Allergic Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for Allergic Diseases industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drugs for Allergic Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Drugs for Allergic Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for Allergic Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for Allergic Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for Allergic Diseases.
Global key players of Targeted Drugs for Allergic Diseases include Sanofi, AbbVie, Novartis, Incyte, Roche, etc. The top five players hold a share over 76%. North America is the largest market, and has a share about 68%, followed by Europe with share 18%. In terms of product type, IL-4R is the largest segment, occupied for a share of 37%. In terms of application, Asthma has a share about 35 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for Allergic Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
Anaphylaxis is an inappropriate reaction of the immune system to normal harmless substances. It generally has a rapid onset, strong reaction, and rapid subsidence. It has obvious genetic tendencies and individual differences. Currently, the prevalence of allergic diseases is increasing rapidly worldwide, affecting approximately 25% of the global population. Abnormalities in type 2 immune pathways are important factors in inducing allergic diseases. Type 2 immune pathway refers to an inflammatory pathway in which Th2 cells (T helper 2) play a key role, and various cytokines such as IL-4, IL-5, IL-13, and TSLP are involved. Depending on where the inflammatory reaction occurs, abnormal type 2 immune pathways can induce different allergic diseases, such as skin (atopic dermatitis, chronic spontaneous urticaria, etc.), respiratory tract (chronic sinusitis, asthma, chronic obstruction, etc.) lung disease, etc.), digestive tract (eosinophilic esophagitis), cardiovascular (eosinophilic granulomatous vasculitis), etc. Biological targeted drugs mainly reduce the inflammatory response and activity of immune cells by binding to targets such as specific regulatory factors in the type 2 immune pathway; Small molecule targeted drugs include JAK inhibitors and TYK2 inhibitors, which exert immunomodulatory effects by blocking the JAK/STAT pathway. Compared with traditional anti-allergic drugs, targeted drugs have better efficacy in severe or drug-resistant patients, and the drugs themselves are safer, and have gradually become the mainstream trend in the development of anti-allergic drugs.
The global Targeted Drugs for Allergic Diseases market size is projected to grow from US$ 36340 million in 2024 to US$ 91900 million in 2030; it is expected to grow at a CAGR of 16.7% from 2024 to 2030.
LPI (LP Information)' newest research report, the “Targeted Drugs for Allergic Diseases Industry Forecast” looks at past sales and reviews total world Targeted Drugs for Allergic Diseases sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Drugs for Allergic Diseases sales for 2023 through 2029. With Targeted Drugs for Allergic Diseases sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drugs for Allergic Diseases industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drugs for Allergic Diseases landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Drugs for Allergic Diseases portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drugs for Allergic Diseases market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drugs for Allergic Diseases and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drugs for Allergic Diseases.
Global key players of Targeted Drugs for Allergic Diseases include Sanofi, AbbVie, Novartis, Incyte, Roche, etc. The top five players hold a share over 76%. North America is the largest market, and has a share about 68%, followed by Europe with share 18%. In terms of product type, IL-4R is the largest segment, occupied for a share of 37%. In terms of application, Asthma has a share about 35 percent.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drugs for Allergic Diseases market by product type, application, key players and key regions and countries.
Segmentation by Type:
- IL-4R
- TSLP
- IL-5
- JAK
- IgE
- IL-13
- Others
- Atopic Dermatitis
- Asthma
- Chronic Sinusitis with Nasal Polyps
- Chronic Obstructive Pulmonary Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- IL-4R
- TSLP
- IL-5
- JAK
- IgE
- IL-13
- Others
- Atopic Dermatitis
- Asthma
- Chronic Sinusitis with Nasal Polyps
- Chronic Obstructive Pulmonary Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- AbbVie
- Novartis
- Incyte
- Roche
- AstraZeneca
- GSK
- Eli Lilly and Company
- Amgen
- Pfizer
- Leo Pharma
- Teva
- Otsuka Pharmaceutical
- Mabpharm
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Drugs for Allergic Diseases Market Size 2019-2030
2.1.2 Targeted Drugs for Allergic Diseases Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Targeted Drugs for Allergic Diseases by Country/Region, 2019, 2023 & 2030
2.2 Targeted Drugs for Allergic Diseases Segment by Type
2.2.1 IL-4R
2.2.2 TSLP
2.2.3 IL-5
2.2.4 JAK
2.2.5 IgE
2.2.6 IL-13
2.2.7 Others
2.3 Targeted Drugs for Allergic Diseases Market Size by Type
2.3.1 Targeted Drugs for Allergic Diseases Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
2.4 Targeted Drugs for Allergic Diseases Segment by Application
2.4.1 Atopic Dermatitis
2.4.2 Asthma
2.4.3 Chronic Sinusitis with Nasal Polyps
2.4.4 Chronic Obstructive Pulmonary Disease
2.4.5 Others
2.5 Targeted Drugs for Allergic Diseases Market Size by Application
2.5.1 Targeted Drugs for Allergic Diseases Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
3 TARGETED DRUGS FOR ALLERGIC DISEASES MARKET SIZE BY PLAYER
3.1 Targeted Drugs for Allergic Diseases Market Size Market Share by Player
3.1.1 Global Targeted Drugs for Allergic Diseases Revenue by Player (2019-2024)
3.1.2 Global Targeted Drugs for Allergic Diseases Revenue Market Share by Player (2019-2024)
3.2 Global Targeted Drugs for Allergic Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED DRUGS FOR ALLERGIC DISEASES BY REGION
4.1 Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024)
4.2 Global Targeted Drugs for Allergic Diseases Annual Revenue by Country/Region (2019-2024)
4.3 Americas Targeted Drugs for Allergic Diseases Market Size Growth (2019-2024)
4.4 APAC Targeted Drugs for Allergic Diseases Market Size Growth (2019-2024)
4.5 Europe Targeted Drugs for Allergic Diseases Market Size Growth (2019-2024)
4.6 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
5.2 Americas Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
5.3 Americas Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024)
6.2 APAC Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
6.3 APAC Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
7.2 Europe Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
7.3 Europe Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Drugs for Allergic Diseases by Region (2019-2024)
8.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED DRUGS FOR ALLERGIC DISEASES MARKET FORECAST
10.1 Global Targeted Drugs for Allergic Diseases Forecast by Region (2025-2030)
10.1.1 Global Targeted Drugs for Allergic Diseases Forecast by Region (2025-2030)
10.1.2 Americas Targeted Drugs for Allergic Diseases Forecast
10.1.3 APAC Targeted Drugs for Allergic Diseases Forecast
10.1.4 Europe Targeted Drugs for Allergic Diseases Forecast
10.1.5 Middle East & Africa Targeted Drugs for Allergic Diseases Forecast
10.2 Americas Targeted Drugs for Allergic Diseases Forecast by Country (2025-2030)
10.2.1 United States Market Targeted Drugs for Allergic Diseases Forecast
10.2.2 Canada Market Targeted Drugs for Allergic Diseases Forecast
10.2.3 Mexico Market Targeted Drugs for Allergic Diseases Forecast
10.2.4 Brazil Market Targeted Drugs for Allergic Diseases Forecast
10.3 APAC Targeted Drugs for Allergic Diseases Forecast by Region (2025-2030)
10.3.1 China Targeted Drugs for Allergic Diseases Market Forecast
10.3.2 Japan Market Targeted Drugs for Allergic Diseases Forecast
10.3.3 Korea Market Targeted Drugs for Allergic Diseases Forecast
10.3.4 Southeast Asia Market Targeted Drugs for Allergic Diseases Forecast
10.3.5 India Market Targeted Drugs for Allergic Diseases Forecast
10.3.6 Australia Market Targeted Drugs for Allergic Diseases Forecast
10.4 Europe Targeted Drugs for Allergic Diseases Forecast by Country (2025-2030)
10.4.1 Germany Market Targeted Drugs for Allergic Diseases Forecast
10.4.2 France Market Targeted Drugs for Allergic Diseases Forecast
10.4.3 UK Market Targeted Drugs for Allergic Diseases Forecast
10.4.4 Italy Market Targeted Drugs for Allergic Diseases Forecast
10.4.5 Russia Market Targeted Drugs for Allergic Diseases Forecast
10.5 Middle East & Africa Targeted Drugs for Allergic Diseases Forecast by Region (2025-2030)
10.5.1 Egypt Market Targeted Drugs for Allergic Diseases Forecast
10.5.2 South Africa Market Targeted Drugs for Allergic Diseases Forecast
10.5.3 Israel Market Targeted Drugs for Allergic Diseases Forecast
10.5.4 Turkey Market Targeted Drugs for Allergic Diseases Forecast
10.6 Global Targeted Drugs for Allergic Diseases Forecast by Type (2025-2030)
10.7 Global Targeted Drugs for Allergic Diseases Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Targeted Drugs for Allergic Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Targeted Drugs for Allergic Diseases Product Offered
11.1.3 Sanofi Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 AbbVie
11.2.1 AbbVie Company Information
11.2.2 AbbVie Targeted Drugs for Allergic Diseases Product Offered
11.2.3 AbbVie Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AbbVie Main Business Overview
11.2.5 AbbVie Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Targeted Drugs for Allergic Diseases Product Offered
11.3.3 Novartis Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Incyte
11.4.1 Incyte Company Information
11.4.2 Incyte Targeted Drugs for Allergic Diseases Product Offered
11.4.3 Incyte Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Incyte Main Business Overview
11.4.5 Incyte Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Targeted Drugs for Allergic Diseases Product Offered
11.5.3 Roche Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Targeted Drugs for Allergic Diseases Product Offered
11.6.3 AstraZeneca Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 GSK
11.7.1 GSK Company Information
11.7.2 GSK Targeted Drugs for Allergic Diseases Product Offered
11.7.3 GSK Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 GSK Main Business Overview
11.7.5 GSK Latest Developments
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Information
11.8.2 Eli Lilly and Company Targeted Drugs for Allergic Diseases Product Offered
11.8.3 Eli Lilly and Company Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Eli Lilly and Company Main Business Overview
11.8.5 Eli Lilly and Company Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Targeted Drugs for Allergic Diseases Product Offered
11.9.3 Amgen Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Targeted Drugs for Allergic Diseases Product Offered
11.10.3 Pfizer Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Leo Pharma
11.11.1 Leo Pharma Company Information
11.11.2 Leo Pharma Targeted Drugs for Allergic Diseases Product Offered
11.11.3 Leo Pharma Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Leo Pharma Main Business Overview
11.11.5 Leo Pharma Latest Developments
11.12 Teva
11.12.1 Teva Company Information
11.12.2 Teva Targeted Drugs for Allergic Diseases Product Offered
11.12.3 Teva Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Teva Main Business Overview
11.12.5 Teva Latest Developments
11.13 Otsuka Pharmaceutical
11.13.1 Otsuka Pharmaceutical Company Information
11.13.2 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Product Offered
11.13.3 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Otsuka Pharmaceutical Main Business Overview
11.13.5 Otsuka Pharmaceutical Latest Developments
11.14 Mabpharm
11.14.1 Mabpharm Company Information
11.14.2 Mabpharm Targeted Drugs for Allergic Diseases Product Offered
11.14.3 Mabpharm Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Mabpharm Main Business Overview
11.14.5 Mabpharm Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Drugs for Allergic Diseases Market Size 2019-2030
2.1.2 Targeted Drugs for Allergic Diseases Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Targeted Drugs for Allergic Diseases by Country/Region, 2019, 2023 & 2030
2.2 Targeted Drugs for Allergic Diseases Segment by Type
2.2.1 IL-4R
2.2.2 TSLP
2.2.3 IL-5
2.2.4 JAK
2.2.5 IgE
2.2.6 IL-13
2.2.7 Others
2.3 Targeted Drugs for Allergic Diseases Market Size by Type
2.3.1 Targeted Drugs for Allergic Diseases Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
2.4 Targeted Drugs for Allergic Diseases Segment by Application
2.4.1 Atopic Dermatitis
2.4.2 Asthma
2.4.3 Chronic Sinusitis with Nasal Polyps
2.4.4 Chronic Obstructive Pulmonary Disease
2.4.5 Others
2.5 Targeted Drugs for Allergic Diseases Market Size by Application
2.5.1 Targeted Drugs for Allergic Diseases Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
3 TARGETED DRUGS FOR ALLERGIC DISEASES MARKET SIZE BY PLAYER
3.1 Targeted Drugs for Allergic Diseases Market Size Market Share by Player
3.1.1 Global Targeted Drugs for Allergic Diseases Revenue by Player (2019-2024)
3.1.2 Global Targeted Drugs for Allergic Diseases Revenue Market Share by Player (2019-2024)
3.2 Global Targeted Drugs for Allergic Diseases Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED DRUGS FOR ALLERGIC DISEASES BY REGION
4.1 Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024)
4.2 Global Targeted Drugs for Allergic Diseases Annual Revenue by Country/Region (2019-2024)
4.3 Americas Targeted Drugs for Allergic Diseases Market Size Growth (2019-2024)
4.4 APAC Targeted Drugs for Allergic Diseases Market Size Growth (2019-2024)
4.5 Europe Targeted Drugs for Allergic Diseases Market Size Growth (2019-2024)
4.6 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
5.2 Americas Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
5.3 Americas Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024)
6.2 APAC Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
6.3 APAC Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024)
7.2 Europe Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
7.3 Europe Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Drugs for Allergic Diseases by Region (2019-2024)
8.2 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024)
8.3 Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED DRUGS FOR ALLERGIC DISEASES MARKET FORECAST
10.1 Global Targeted Drugs for Allergic Diseases Forecast by Region (2025-2030)
10.1.1 Global Targeted Drugs for Allergic Diseases Forecast by Region (2025-2030)
10.1.2 Americas Targeted Drugs for Allergic Diseases Forecast
10.1.3 APAC Targeted Drugs for Allergic Diseases Forecast
10.1.4 Europe Targeted Drugs for Allergic Diseases Forecast
10.1.5 Middle East & Africa Targeted Drugs for Allergic Diseases Forecast
10.2 Americas Targeted Drugs for Allergic Diseases Forecast by Country (2025-2030)
10.2.1 United States Market Targeted Drugs for Allergic Diseases Forecast
10.2.2 Canada Market Targeted Drugs for Allergic Diseases Forecast
10.2.3 Mexico Market Targeted Drugs for Allergic Diseases Forecast
10.2.4 Brazil Market Targeted Drugs for Allergic Diseases Forecast
10.3 APAC Targeted Drugs for Allergic Diseases Forecast by Region (2025-2030)
10.3.1 China Targeted Drugs for Allergic Diseases Market Forecast
10.3.2 Japan Market Targeted Drugs for Allergic Diseases Forecast
10.3.3 Korea Market Targeted Drugs for Allergic Diseases Forecast
10.3.4 Southeast Asia Market Targeted Drugs for Allergic Diseases Forecast
10.3.5 India Market Targeted Drugs for Allergic Diseases Forecast
10.3.6 Australia Market Targeted Drugs for Allergic Diseases Forecast
10.4 Europe Targeted Drugs for Allergic Diseases Forecast by Country (2025-2030)
10.4.1 Germany Market Targeted Drugs for Allergic Diseases Forecast
10.4.2 France Market Targeted Drugs for Allergic Diseases Forecast
10.4.3 UK Market Targeted Drugs for Allergic Diseases Forecast
10.4.4 Italy Market Targeted Drugs for Allergic Diseases Forecast
10.4.5 Russia Market Targeted Drugs for Allergic Diseases Forecast
10.5 Middle East & Africa Targeted Drugs for Allergic Diseases Forecast by Region (2025-2030)
10.5.1 Egypt Market Targeted Drugs for Allergic Diseases Forecast
10.5.2 South Africa Market Targeted Drugs for Allergic Diseases Forecast
10.5.3 Israel Market Targeted Drugs for Allergic Diseases Forecast
10.5.4 Turkey Market Targeted Drugs for Allergic Diseases Forecast
10.6 Global Targeted Drugs for Allergic Diseases Forecast by Type (2025-2030)
10.7 Global Targeted Drugs for Allergic Diseases Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Targeted Drugs for Allergic Diseases Forecast
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Targeted Drugs for Allergic Diseases Product Offered
11.1.3 Sanofi Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 AbbVie
11.2.1 AbbVie Company Information
11.2.2 AbbVie Targeted Drugs for Allergic Diseases Product Offered
11.2.3 AbbVie Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AbbVie Main Business Overview
11.2.5 AbbVie Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Targeted Drugs for Allergic Diseases Product Offered
11.3.3 Novartis Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Incyte
11.4.1 Incyte Company Information
11.4.2 Incyte Targeted Drugs for Allergic Diseases Product Offered
11.4.3 Incyte Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Incyte Main Business Overview
11.4.5 Incyte Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Targeted Drugs for Allergic Diseases Product Offered
11.5.3 Roche Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Targeted Drugs for Allergic Diseases Product Offered
11.6.3 AstraZeneca Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 GSK
11.7.1 GSK Company Information
11.7.2 GSK Targeted Drugs for Allergic Diseases Product Offered
11.7.3 GSK Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 GSK Main Business Overview
11.7.5 GSK Latest Developments
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Information
11.8.2 Eli Lilly and Company Targeted Drugs for Allergic Diseases Product Offered
11.8.3 Eli Lilly and Company Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Eli Lilly and Company Main Business Overview
11.8.5 Eli Lilly and Company Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Targeted Drugs for Allergic Diseases Product Offered
11.9.3 Amgen Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Targeted Drugs for Allergic Diseases Product Offered
11.10.3 Pfizer Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Leo Pharma
11.11.1 Leo Pharma Company Information
11.11.2 Leo Pharma Targeted Drugs for Allergic Diseases Product Offered
11.11.3 Leo Pharma Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Leo Pharma Main Business Overview
11.11.5 Leo Pharma Latest Developments
11.12 Teva
11.12.1 Teva Company Information
11.12.2 Teva Targeted Drugs for Allergic Diseases Product Offered
11.12.3 Teva Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Teva Main Business Overview
11.12.5 Teva Latest Developments
11.13 Otsuka Pharmaceutical
11.13.1 Otsuka Pharmaceutical Company Information
11.13.2 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Product Offered
11.13.3 Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Otsuka Pharmaceutical Main Business Overview
11.13.5 Otsuka Pharmaceutical Latest Developments
11.14 Mabpharm
11.14.1 Mabpharm Company Information
11.14.2 Mabpharm Targeted Drugs for Allergic Diseases Product Offered
11.14.3 Mabpharm Targeted Drugs for Allergic Diseases Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Mabpharm Main Business Overview
11.14.5 Mabpharm Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Drugs for Allergic Diseases Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Targeted Drugs for Allergic Diseases Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of IL-4R
Table 4. Major Players of TSLP
Table 5. Major Players of IL-5
Table 6. Major Players of JAK
Table 7. Major Players of IgE
Table 8. Major Players of IL-13
Table 9. Major Players of Others
Table 10. Targeted Drugs for Allergic Diseases Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & ($ millions)
Table 12. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
Table 13. Targeted Drugs for Allergic Diseases Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 14. Global Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & ($ millions)
Table 15. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
Table 16. Global Targeted Drugs for Allergic Diseases Revenue by Player (2019-2024) & ($ millions)
Table 17. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Player (2019-2024)
Table 18. Targeted Drugs for Allergic Diseases Key Players Head office and Products Offered
Table 19. Targeted Drugs for Allergic Diseases Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) & ($ millions)
Table 23. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2019-2024)
Table 24. Global Targeted Drugs for Allergic Diseases Revenue by Country/Region (2019-2024) & ($ millions)
Table 25. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Country/Region (2019-2024)
Table 26. Americas Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & ($ millions)
Table 27. Americas Targeted Drugs for Allergic Diseases Market Size Market Share by Country (2019-2024)
Table 28. Americas Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & ($ millions)
Table 29. Americas Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
Table 30. Americas Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & ($ millions)
Table 31. Americas Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
Table 32. APAC Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) & ($ millions)
Table 33. APAC Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2019-2024)
Table 34. APAC Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & ($ millions)
Table 35. APAC Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & ($ millions)
Table 36. Europe Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & ($ millions)
Table 37. Europe Targeted Drugs for Allergic Diseases Market Size Market Share by Country (2019-2024)
Table 38. Europe Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & ($ millions)
Table 39. Europe Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & ($ millions)
Table 40. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) & ($ millions)
Table 41. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & ($ millions)
Table 42. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & ($ millions)
Table 43. Key Market Drivers & Growth Opportunities of Targeted Drugs for Allergic Diseases
Table 44. Key Market Challenges & Risks of Targeted Drugs for Allergic Diseases
Table 45. Key Industry Trends of Targeted Drugs for Allergic Diseases
Table 46. Global Targeted Drugs for Allergic Diseases Market Size Forecast by Region (2025-2030) & ($ millions)
Table 47. Global Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Region (2025-2030)
Table 48. Global Targeted Drugs for Allergic Diseases Market Size Forecast by Type (2025-2030) & ($ millions)
Table 49. Global Targeted Drugs for Allergic Diseases Market Size Forecast by Application (2025-2030) & ($ millions)
Table 50. Sanofi Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 51. Sanofi Targeted Drugs for Allergic Diseases Product Offered
Table 52. Sanofi Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Sanofi Main Business
Table 54. Sanofi Latest Developments
Table 55. AbbVie Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 56. AbbVie Targeted Drugs for Allergic Diseases Product Offered
Table 57. AbbVie Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. AbbVie Main Business
Table 59. AbbVie Latest Developments
Table 60. Novartis Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 61. Novartis Targeted Drugs for Allergic Diseases Product Offered
Table 62. Novartis Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Novartis Main Business
Table 64. Novartis Latest Developments
Table 65. Incyte Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 66. Incyte Targeted Drugs for Allergic Diseases Product Offered
Table 67. Incyte Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Incyte Main Business
Table 69. Incyte Latest Developments
Table 70. Roche Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 71. Roche Targeted Drugs for Allergic Diseases Product Offered
Table 72. Roche Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Roche Main Business
Table 74. Roche Latest Developments
Table 75. AstraZeneca Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 76. AstraZeneca Targeted Drugs for Allergic Diseases Product Offered
Table 77. AstraZeneca Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. AstraZeneca Main Business
Table 79. AstraZeneca Latest Developments
Table 80. GSK Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 81. GSK Targeted Drugs for Allergic Diseases Product Offered
Table 82. GSK Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Eli Lilly and Company Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 86. Eli Lilly and Company Targeted Drugs for Allergic Diseases Product Offered
Table 87. Eli Lilly and Company Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Eli Lilly and Company Main Business
Table 89. Eli Lilly and Company Latest Developments
Table 90. Amgen Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 91. Amgen Targeted Drugs for Allergic Diseases Product Offered
Table 92. Amgen Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Amgen Main Business
Table 94. Amgen Latest Developments
Table 95. Pfizer Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 96. Pfizer Targeted Drugs for Allergic Diseases Product Offered
Table 97. Pfizer Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Leo Pharma Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 101. Leo Pharma Targeted Drugs for Allergic Diseases Product Offered
Table 102. Leo Pharma Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Leo Pharma Main Business
Table 104. Leo Pharma Latest Developments
Table 105. Teva Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 106. Teva Targeted Drugs for Allergic Diseases Product Offered
Table 107. Teva Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Teva Main Business
Table 109. Teva Latest Developments
Table 110. Otsuka Pharmaceutical Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 111. Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Product Offered
Table 112. Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Otsuka Pharmaceutical Main Business
Table 114. Otsuka Pharmaceutical Latest Developments
Table 115. Mabpharm Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 116. Mabpharm Targeted Drugs for Allergic Diseases Product Offered
Table 117. Mabpharm Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Mabpharm Main Business
Table 119. Mabpharm Latest Developments
Table 1. Targeted Drugs for Allergic Diseases Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Targeted Drugs for Allergic Diseases Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of IL-4R
Table 4. Major Players of TSLP
Table 5. Major Players of IL-5
Table 6. Major Players of JAK
Table 7. Major Players of IgE
Table 8. Major Players of IL-13
Table 9. Major Players of Others
Table 10. Targeted Drugs for Allergic Diseases Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 11. Global Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & ($ millions)
Table 12. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
Table 13. Targeted Drugs for Allergic Diseases Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 14. Global Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & ($ millions)
Table 15. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
Table 16. Global Targeted Drugs for Allergic Diseases Revenue by Player (2019-2024) & ($ millions)
Table 17. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Player (2019-2024)
Table 18. Targeted Drugs for Allergic Diseases Key Players Head office and Products Offered
Table 19. Targeted Drugs for Allergic Diseases Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) & ($ millions)
Table 23. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2019-2024)
Table 24. Global Targeted Drugs for Allergic Diseases Revenue by Country/Region (2019-2024) & ($ millions)
Table 25. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Country/Region (2019-2024)
Table 26. Americas Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & ($ millions)
Table 27. Americas Targeted Drugs for Allergic Diseases Market Size Market Share by Country (2019-2024)
Table 28. Americas Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & ($ millions)
Table 29. Americas Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
Table 30. Americas Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & ($ millions)
Table 31. Americas Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
Table 32. APAC Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) & ($ millions)
Table 33. APAC Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2019-2024)
Table 34. APAC Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & ($ millions)
Table 35. APAC Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & ($ millions)
Table 36. Europe Targeted Drugs for Allergic Diseases Market Size by Country (2019-2024) & ($ millions)
Table 37. Europe Targeted Drugs for Allergic Diseases Market Size Market Share by Country (2019-2024)
Table 38. Europe Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & ($ millions)
Table 39. Europe Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & ($ millions)
Table 40. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Region (2019-2024) & ($ millions)
Table 41. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Type (2019-2024) & ($ millions)
Table 42. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size by Application (2019-2024) & ($ millions)
Table 43. Key Market Drivers & Growth Opportunities of Targeted Drugs for Allergic Diseases
Table 44. Key Market Challenges & Risks of Targeted Drugs for Allergic Diseases
Table 45. Key Industry Trends of Targeted Drugs for Allergic Diseases
Table 46. Global Targeted Drugs for Allergic Diseases Market Size Forecast by Region (2025-2030) & ($ millions)
Table 47. Global Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Region (2025-2030)
Table 48. Global Targeted Drugs for Allergic Diseases Market Size Forecast by Type (2025-2030) & ($ millions)
Table 49. Global Targeted Drugs for Allergic Diseases Market Size Forecast by Application (2025-2030) & ($ millions)
Table 50. Sanofi Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 51. Sanofi Targeted Drugs for Allergic Diseases Product Offered
Table 52. Sanofi Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Sanofi Main Business
Table 54. Sanofi Latest Developments
Table 55. AbbVie Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 56. AbbVie Targeted Drugs for Allergic Diseases Product Offered
Table 57. AbbVie Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. AbbVie Main Business
Table 59. AbbVie Latest Developments
Table 60. Novartis Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 61. Novartis Targeted Drugs for Allergic Diseases Product Offered
Table 62. Novartis Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Novartis Main Business
Table 64. Novartis Latest Developments
Table 65. Incyte Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 66. Incyte Targeted Drugs for Allergic Diseases Product Offered
Table 67. Incyte Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Incyte Main Business
Table 69. Incyte Latest Developments
Table 70. Roche Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 71. Roche Targeted Drugs for Allergic Diseases Product Offered
Table 72. Roche Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Roche Main Business
Table 74. Roche Latest Developments
Table 75. AstraZeneca Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 76. AstraZeneca Targeted Drugs for Allergic Diseases Product Offered
Table 77. AstraZeneca Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. AstraZeneca Main Business
Table 79. AstraZeneca Latest Developments
Table 80. GSK Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 81. GSK Targeted Drugs for Allergic Diseases Product Offered
Table 82. GSK Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Eli Lilly and Company Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 86. Eli Lilly and Company Targeted Drugs for Allergic Diseases Product Offered
Table 87. Eli Lilly and Company Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Eli Lilly and Company Main Business
Table 89. Eli Lilly and Company Latest Developments
Table 90. Amgen Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 91. Amgen Targeted Drugs for Allergic Diseases Product Offered
Table 92. Amgen Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Amgen Main Business
Table 94. Amgen Latest Developments
Table 95. Pfizer Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 96. Pfizer Targeted Drugs for Allergic Diseases Product Offered
Table 97. Pfizer Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Leo Pharma Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 101. Leo Pharma Targeted Drugs for Allergic Diseases Product Offered
Table 102. Leo Pharma Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Leo Pharma Main Business
Table 104. Leo Pharma Latest Developments
Table 105. Teva Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 106. Teva Targeted Drugs for Allergic Diseases Product Offered
Table 107. Teva Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Teva Main Business
Table 109. Teva Latest Developments
Table 110. Otsuka Pharmaceutical Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 111. Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Product Offered
Table 112. Otsuka Pharmaceutical Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Otsuka Pharmaceutical Main Business
Table 114. Otsuka Pharmaceutical Latest Developments
Table 115. Mabpharm Details, Company Type, Targeted Drugs for Allergic Diseases Area Served and Its Competitors
Table 116. Mabpharm Targeted Drugs for Allergic Diseases Product Offered
Table 117. Mabpharm Targeted Drugs for Allergic Diseases Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Mabpharm Main Business
Table 119. Mabpharm Latest Developments
LIST OF FIGURES
Figure 1. Targeted Drugs for Allergic Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Drugs for Allergic Diseases Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Targeted Drugs for Allergic Diseases Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Targeted Drugs for Allergic Diseases Sales Market Share by Country/Region (2023)
Figure 8. Targeted Drugs for Allergic Diseases Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Type in 2023
Figure 10. Targeted Drugs for Allergic Diseases in Atopic Dermatitis
Figure 11. Global Targeted Drugs for Allergic Diseases Market: Atopic Dermatitis (2019-2024) & ($ millions)
Figure 12. Targeted Drugs for Allergic Diseases in Asthma
Figure 13. Global Targeted Drugs for Allergic Diseases Market: Asthma (2019-2024) & ($ millions)
Figure 14. Targeted Drugs for Allergic Diseases in Chronic Sinusitis with Nasal Polyps
Figure 15. Global Targeted Drugs for Allergic Diseases Market: Chronic Sinusitis with Nasal Polyps (2019-2024) & ($ millions)
Figure 16. Targeted Drugs for Allergic Diseases in Chronic Obstructive Pulmonary Disease
Figure 17. Global Targeted Drugs for Allergic Diseases Market: Chronic Obstructive Pulmonary Disease (2019-2024) & ($ millions)
Figure 18. Targeted Drugs for Allergic Diseases in Others
Figure 19. Global Targeted Drugs for Allergic Diseases Market: Others (2019-2024) & ($ millions)
Figure 20. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Application in 2023
Figure 21. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Player in 2023
Figure 22. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2019-2024)
Figure 23. Americas Targeted Drugs for Allergic Diseases Market Size 2019-2024 ($ millions)
Figure 24. APAC Targeted Drugs for Allergic Diseases Market Size 2019-2024 ($ millions)
Figure 25. Europe Targeted Drugs for Allergic Diseases Market Size 2019-2024 ($ millions)
Figure 26. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size 2019-2024 ($ millions)
Figure 27. Americas Targeted Drugs for Allergic Diseases Value Market Share by Country in 2023
Figure 28. United States Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 29. Canada Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 30. Mexico Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 31. Brazil Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 32. APAC Targeted Drugs for Allergic Diseases Market Size Market Share by Region in 2023
Figure 33. APAC Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
Figure 34. APAC Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
Figure 35. China Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 36. Japan Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 37. South Korea Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 38. Southeast Asia Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 39. India Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 40. Australia Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 41. Europe Targeted Drugs for Allergic Diseases Market Size Market Share by Country in 2023
Figure 42. Europe Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
Figure 43. Europe Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
Figure 44. Germany Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 45. France Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 46. UK Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 47. Italy Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 48. Russia Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 49. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 53. South Africa Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 54. Israel Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 55. Turkey Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 56. GCC Countries Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 57. Americas Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 58. APAC Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 59. Europe Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 60. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 61. United States Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 62. Canada Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 63. Mexico Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 64. Brazil Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 65. China Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 66. Japan Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 67. Korea Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 68. Southeast Asia Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 69. India Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 70. Australia Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 71. Germany Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 72. France Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 73. UK Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 74. Italy Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 75. Russia Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 76. Egypt Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 77. South Africa Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 78. Israel Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 79. Turkey Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 80. GCC Countries Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 81. Global Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Type (2025-2030)
Figure 82. Global Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Targeted Drugs for Allergic Diseases Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Drugs for Allergic Diseases Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Targeted Drugs for Allergic Diseases Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Targeted Drugs for Allergic Diseases Sales Market Share by Country/Region (2023)
Figure 8. Targeted Drugs for Allergic Diseases Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Type in 2023
Figure 10. Targeted Drugs for Allergic Diseases in Atopic Dermatitis
Figure 11. Global Targeted Drugs for Allergic Diseases Market: Atopic Dermatitis (2019-2024) & ($ millions)
Figure 12. Targeted Drugs for Allergic Diseases in Asthma
Figure 13. Global Targeted Drugs for Allergic Diseases Market: Asthma (2019-2024) & ($ millions)
Figure 14. Targeted Drugs for Allergic Diseases in Chronic Sinusitis with Nasal Polyps
Figure 15. Global Targeted Drugs for Allergic Diseases Market: Chronic Sinusitis with Nasal Polyps (2019-2024) & ($ millions)
Figure 16. Targeted Drugs for Allergic Diseases in Chronic Obstructive Pulmonary Disease
Figure 17. Global Targeted Drugs for Allergic Diseases Market: Chronic Obstructive Pulmonary Disease (2019-2024) & ($ millions)
Figure 18. Targeted Drugs for Allergic Diseases in Others
Figure 19. Global Targeted Drugs for Allergic Diseases Market: Others (2019-2024) & ($ millions)
Figure 20. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Application in 2023
Figure 21. Global Targeted Drugs for Allergic Diseases Revenue Market Share by Player in 2023
Figure 22. Global Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2019-2024)
Figure 23. Americas Targeted Drugs for Allergic Diseases Market Size 2019-2024 ($ millions)
Figure 24. APAC Targeted Drugs for Allergic Diseases Market Size 2019-2024 ($ millions)
Figure 25. Europe Targeted Drugs for Allergic Diseases Market Size 2019-2024 ($ millions)
Figure 26. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size 2019-2024 ($ millions)
Figure 27. Americas Targeted Drugs for Allergic Diseases Value Market Share by Country in 2023
Figure 28. United States Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 29. Canada Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 30. Mexico Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 31. Brazil Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 32. APAC Targeted Drugs for Allergic Diseases Market Size Market Share by Region in 2023
Figure 33. APAC Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
Figure 34. APAC Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
Figure 35. China Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 36. Japan Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 37. South Korea Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 38. Southeast Asia Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 39. India Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 40. Australia Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 41. Europe Targeted Drugs for Allergic Diseases Market Size Market Share by Country in 2023
Figure 42. Europe Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
Figure 43. Europe Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
Figure 44. Germany Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 45. France Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 46. UK Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 47. Italy Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 48. Russia Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 49. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 53. South Africa Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 54. Israel Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 55. Turkey Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 56. GCC Countries Targeted Drugs for Allergic Diseases Market Size Growth 2019-2024 ($ millions)
Figure 57. Americas Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 58. APAC Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 59. Europe Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 60. Middle East & Africa Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 61. United States Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 62. Canada Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 63. Mexico Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 64. Brazil Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 65. China Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 66. Japan Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 67. Korea Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 68. Southeast Asia Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 69. India Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 70. Australia Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 71. Germany Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 72. France Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 73. UK Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 74. Italy Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 75. Russia Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 76. Egypt Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 77. South Africa Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 78. Israel Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 79. Turkey Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 80. GCC Countries Targeted Drugs for Allergic Diseases Market Size 2025-2030 ($ millions)
Figure 81. Global Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Type (2025-2030)
Figure 82. Global Targeted Drugs for Allergic Diseases Market Size Market Share Forecast by Application (2025-2030)
